9 Results for "

osteogenesis imperfecta

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "osteogenesis imperfecta" in MCE Product Catalog:

6
6 Cited Publications
Cat. No.: HY-P81227
Synonyms: Collagen type I; Alpha 1 type I collagen; Alpha 2 type I collagen; COL1A1; COL1A2; Collagen I alpha 1 polypeptide; Collagen I alpha 2 polypeptide; Collagen Of Skin Tendon And Bone; Collagen Type 1; Collagen type I alpha 1; Collagen type I alpha 2; OI4; osteogenesis imperfecta Type IV; Pro alpha 1(I) collagen; Type I procollagen; CO1A1_HUMAN.

Host:  

Rabbit

Application:  

WB, IHC-P

Reactivity:  

Human, Mouse, Rat, Rabbit

loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P99020
CAS No.: 948564-73-6
Synonyms: GC1008

Target:  

TGF-beta/Smad

Research Areas:  

Inflammation/Immunology Cancer

Fresolimumab (GC1008) is a human monoclonal antibody against TGF-β that neutralizes all mammalian active subtypes of TGF-β. The binding affinity of Fresolimumab to TGF-β2 is 1.8 nM. Fresolimumab improves Bleomycin (HY-108345)-induced acute lung injury. Fresolimumab radiolabeled with 89Zr can be used for PET analysis of TGF-β expression, antibody uptake and organ distribution. Fresolimumab can be used in the study of cancer, osteogenesis imperfecta, fibrosis and kidney disease .
loading...
    loading...
Cat. No.: HY-119443
CAS No.: 79778-41-9
Purity:  ≥98.0%
Target:  

Apoptosis

Neridronate is a bisphosphonate. Bisphosphonates initiate the Apoptotic process. Neridronate sodium reduces the levels of bone resorption, bone turnover markers, the degree of back pain, and the risk of fractures. Neridronate inhibits capillary tube formation. Neridronate itself has weak anticancer activity, but liposomal encapsulation enhances this activity. Neridronate can be used in research related to demineralizing metabolic bone diseases, thalassemia-associated osteoporosis, chronic inflammatory diseases, cancer, and osteogenesis imperfecta .
loading...
    loading...
Cat. No.: HY-P99398
CAS No.: 1847394-95-9
Synonyms: BPS 804

Target:  

Inhibitory Antibodies

Research Areas:  

Inflammation/Immunology Cancer

Setrusumab (BPS 804) is a fully human monoclonal antibody targets sclerostin. Setrusumab efftively improves bone strength. Setrusumab can be used for the resesrch of Osteogenesis Imperfecta (OI) and cancer .
loading...
    loading...
Cat. No.: HY-108303
CAS No.: 80729-79-9
Neridronate sodium is a bisphosphonate. Bisphosphonates initiate the Apoptotic process. Neridronate sodium reduces the levels of bone resorption, bone turnover markers, the degree of back pain, and the risk of fractures. Neridronate sodium inhibits capillary tube formation. Neridronate sodium itself has weak anticancer activity, but liposomal encapsulation enhances this activity. Neridronate sodium can be used in research related to demineralizing metabolic bone diseases, thalassemia-associated osteoporosis, chronic inflammatory diseases, cancer, and osteogenesis imperfecta .
loading...
    loading...
Cat. No.: HY-119443R
CAS No.: 79778-41-9
Neridronate (Standard) is the analytical standard of Neridronate (HY-119443). This product is intended for research and analytical applications. Neridronate is a bisphosphonate. Bisphosphonates initiate the Apoptotic process. Neridronate sodium reduces the levels of bone resorption, bone turnover markers, the degree of back pain, and the risk of fractures. Neridronate inhibits capillary tube formation. Neridronate itself has weak anticancer activity, but liposomal encapsulation enhances this activity. Neridronate can be used in research related to demineralizing metabolic bone diseases, thalassemia-associated osteoporosis, chronic inflammatory diseases, cancer, and osteogenesis imperfecta .
loading...
    loading...
Cat. No.: HY-106431
CAS No.: 63132-39-8
Purity:  ≥95.0%
Synonyms: Olpadronate; OLP
Olpadronic acid (Olpadronate) is an orally active amino-bisphosphonate and inhibits bone resorption. Olpadronic acid prevents bone destruction and tumor growth in the skeletal prostate cancer mouse model. Olpadronic acid can be used for research of osteoporosis, malignancies and rheumatoid arthritis .
loading...
    loading...
Cat. No.: HY-185590
CAS No.: 3084453-02-8
Research Areas:  

Cancer

tri-GalNAc-phosphoric acid is a specific ligand of ASGPR with cell-specific internalization capability. tri-GalNAc-phosphoric acid can mediate the delivery of conjugated sclerostin aptamers to lysosomes of cells expressing ASGPR. tri-GalNAc-phosphoric acid is applicable to anticancer research .
loading...
    loading...
Cat. No.: HY-P76284
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CREB3L1; osteogenesis imperfecta, Type XVI; CAMP Responsive Element Binding Protein 3 Like 1; BBF-2 Homolog (Drosophila); OASIS; BBF-2 Homolog; Cyclic AMP-Responsive Element-Binding Protein 3-Like Protein 1; C16DELp11.2; CAMP-Responsive Element-Binding Pr
Species:  
Source:  
loading...
    loading...